Dizal (Jiangsu) Pharmaceutical Co., Ltd. (SHA:688192)
China
· Delayed Price · Currency is CNY 85.21
+2.84 (3.45%)
At close: Aug 15, 2025, 2:57 PM CST
SHA:688192 Market Cap
SHA:688192 has a market cap or net worth of 39.15 billion as of August 15, 2025. Its market cap has increased by 125.53% in one year.
Market Cap
39.15B
Enterprise Value
39.68B
Revenue
438.22M
Ranking
n/a
PE Ratio
n/a
Stock Price
85.21
Market Cap Chart
Since December 10, 2021, SHA:688192's market cap has increased from 16.44B to 39.15B, an increase of 138.12%. That is a compound annual growth rate of 26.57%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 39.15B | 127.11% |
| Dec 31, 2024 | 17.24B | -11.74% |
| Dec 29, 2023 | 19.53B | 21.84% |
| Dec 30, 2022 | 16.03B | 7.16% |
| Dec 31, 2021 | 14.96B | -9.01% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 417.74B |
| WuXi AppTec | 286.10B |
| Shenzhen Mindray Bio-Medical Electronics | 286.01B |
| Sichuan Biokin Pharmaceutical | 126.19B |
| Zhangzhou Pientzehuang Pharmaceutical., | 121.00B |
| Aier Eye Hospital Group | 120.01B |
| Shanghai United Imaging Healthcare | 104.90B |
| Yunnan Baiyao Group Co.,Ltd | 99.92B |